跳到正文
原文
Endpoints News 生物医药· Anna Brown·· 2026-10-12AI 评分31

Undecimal Bio 携 1800 万美元融资成立,计划将 siRNA 拓展至肝外疾病

Undecimal Bio launches with $18M to take siRNA beyond liver disease

AI 导读

Eleven Therapeutics 将业务拆分,Undecimal Bio 携带 1800 万美元融资正式成立,目标是把 siRNA 技术拓展至肝脏以外的疾病领域。

正文

Af­ter spin­ning out one half of its busi­ness this sum­mer, Eleven Ther­a­peu­tics is carv­ing out the oth­er half with $18 mil­lion to join com­pa­nies like …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news